InSite Vision starts conjunctivitis Phase II

ISV started a placebo-controlled Phase II study to compare its ISV-401 DuraSite polymer-based eye drop formulation to a 1% ISV-401 antibiotic solution in 30 patients with confirmed bacterial conjuncti...